Guidelines for the prevention, detection and management of the renal complications of COVID-19 in Africa

African Journal of Nephrology

article

Hesham M Elsayed¹  Shoyab Wadee²  Mohamed S Zaki³  Anthony JO Were⁴  Gloria E Ashuntantang⁵  Ebun L Bamgboye⁶  Mogamat Razeen Davids⁷  Mohamed H Hafez⁸  Maimouna Mahamat⁵  Saraladevi Naicker⁹  Abdou Niang^1,10  Sidy M Seck^1,11  Charles R Swanepoel^1,12  Elliot K Tannor^1,13  Ahmed Twahir^1,14  K Hubert Yao^1,15 

[1] Departments of Internal Medicine and Nephrology, Ain Shams Medical University;Wits Donald Gordon Medical Centre, University of the Witwatersrand;Nephrology Department, National Institute of Urology and Nephrology;East African Kidney Institute, and Department of Medicine, College of Health Sciences, University of Nairobi;Department of Internal Medicine, Yaoundé General Hospital and University of Yaoundé I;St Nicholas Hospital;Division of Nephrology, Stellenbosch University and Tygerberg Hospital;Nephrology Department, Faculty of Medicine, Cairo University;Department of Internal Medicine, School of Clinical Medicine, University of the Witwatersrand;Department of Nephrology, Cheikh Anta Diop University;Departments ofInternal Medicine and Nephrology, Faculty of Health Sciences, Gaston Berger University;Division of Nephrology, Department of Medicine, University of Cape Town;Renal Unit, Department of Medicine, Komfo Anokye Teaching Hospital;Parklands Kidney Centre and Aga Khan University Hospital;University Hospital of Treichville, Felix Houphouet-Boigny University

关键词: COVID-19;    Africa;    dialysis;    transplantation;    acute kidney injury.;   

DOI  :  10.21804/23-1-4097

学科分类：数学（综合）

来源: African Association of Nephrology

【 摘 要 】

Africa trails the rest of the world in COVID-19 cases and deaths. However, as the pandemic spreads through the continent, we expect increases in community infection in the months ahead. Patients with kidney infection, especially those with end-stage kidney disease and those with kidney transplants, are at high risk for acquiring the disease and dying from it. While there is limited evidence for the benefit of interventions, we have the advantage of learning from the experiences of those in China, Europe and the Americas. This document sets forth guidance for dealing with our patients who have acute and chronic kidney disease, including those on renal replacement therapy and the staff involved in their care. Emphasis is placed on preparedness and prevention strategies. As evidence and experience accumulate, it is likely that updated guidance will be needed.L’Afrique suit le reste du monde en termes de nombre de cas et de décès dus à COVID-19. Cependant, alors que la pandémie se propage à travers le continent, nous prévoyons une augmentation de l’infection communautaire dans les mois à venir. Les patients atteints d’une maladie rénale, en particulier ceux atteints d’une maladie rénale chronique en phase terminale et ceux ayant subi une transplantation rénale, courent un risque élevé de contracter la maladie et d’en mourir. Bien que les preuves d’interventions soient limitées, nous avons l’avantage de tirer des enseignements des expériences de ceux qui se trouvent en Chine, en Europe et dans les Amériques. Ce document présente des conseils pour traiter nos patients atteints d’insuffisance rénale aiguë et chronique, y compris ceux sous thérapie de suppléance rénale et le personnel impliqué dans leurs soins. L’accent est mis sur les stratégies de préparation et de prévention. Au fur et à mesure que les preuves et l’expérience s’accumulent, il est probable que des directives actualisées seront nécessaires.

【 授权许可】

CC BY